The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review
Open accessAbstract
Gastric cancer remains one of the most common cancers worldwide and one of the leading cause for cancer-related deaths. Gastric adenocarcinoma is a multifactorial disease that is genetically, cytologically and architecturally more heterogeneous than other gastrointestinal carcinomas. The aberrant activation of the Wnt/β-catenin signaling pathway is involved in the development and progression of a significant proportion of gastric cancer cases. This review focuses on the participation of the Wnt/β-catenin pathway in gastric cancer by offering an analysis of the relevant literature published in this field. Indeed, it is discussed the role of key factors in Wnt/β-catenin signaling and their downstream effectors regulating processes involved in tumor initiation, tumor growth, metastasis and resistance to therapy. Available data indicate that constitutive Wnt signalling resulting from Helicobacter pylori infection and inactivation of Wnt inhibitors (mainly by inactivating mutations and promoter hypermethylation) play an important role in gastric cancer. Moreover, a number of recent studies confirmed CTNNB1 and APC as driver genes in gastric cancer. The identification of specific membrane, intracellular, and extracellular components of the Wnt pathway has revealed potential targets for gastric cancer therapy. High-throughput "omics" approaches will help in the search for Wnt pathway antagonist in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–228 of 228
Characterization of the Differentiation Capacity of Rat-Derived Hepatic Stem Cells
Alison, M. R. (2003) · Seminars in Liver Disease · doi:10.1055/s-2004-815561 · Cited by 45
Wang, X., Huang, C., Yu, G., Wang, J., Wang, R. Y., Li, Y., & Wu, Q. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.01.027 · Cited by 45
Zhang, Y., Miao, F., Geng, J., Wang, R., & Chen, L. (2010) · Neoplasma · doi:10.4149/neo_2010_03_228 · Cited by 44
Henderson, B. R., Galea, M. A., Schüchner, S., & Leung, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110602200 · Cited by 41
Wnt pathway is involved in advanced gastric carcinoma.
Zhang, H., & Xue, Y. (2008) · PubMed · Cited by 40
Liu, M., Yang, S., Wang, Y., Zhu, H., Yan, S., Zhang, W., Quan, L., Bai, J., & Xu, N. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20471 · Cited by 40
Zhang, J., Zhou, B., Liu, Y., Chen, K., Bao, P., Wang, Y., Wang, J., Zhou, Z., Sun, X., & Li, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.011 · Cited by 39
Cui, J., Xi, H., Cai, A., Bian, S., Wei, B., & Chen, L. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1759 · Cited by 38
A two-microRNA signature as a potential biomarker for early gastric cancer
Zheng, G., Xiong, Y., Xu, W., Wang, Y., Chen, F., Wang, Z., & Yan, Z. P. (2014) · Oncology Letters · doi:10.3892/ol.2014.1797 · Cited by 36
Wang, S., Tian, Y., Wu, D., Zhu, H., Luo, D., Gong, W., Zhou, Y., Zhou, J., & Zhang, Z. (2012) · Mutagenesis · doi:10.1093/mutage/ges027 · Cited by 36
Cell cycle regulators, APC/β-catenin, NF-κB and Epstein-Barr virus in gastric carcinomas
Kim, B., Byun, S.-J., Kim, Y. A., Kim, J. E., Lee, B. L., Kim, W. H., & Chang, M. S. (2009) · Pathology · doi:10.3109/00313020903356392 · Cited by 36
RASSF10 is epigenetically silenced and functions as a tumor suppressor in gastric cancer
Wei, Z., Chen, X., Ji, C., Wang, W., Xu, X., & Cai, Q. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.033 · Cited by 35
Yao, J., Qian, C., Shu, T., Zhang, X., Zhao, Z., & Liang, Y. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25332 · Cited by 34
Otani, K., Dong, Y., Li, X., Lü, J., Zhang, N., Xu, L., Go, M. Y., Ng, E. K., Arakawa, T., Chan, F. K. L., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4391 · Cited by 33
Inhibition of β-catenin-mediated transactivation by flavanone in AGS gastric cancer cells
Park, C. H., Hahm, E., Lee, J. H., Jung, K. C., & Yang, C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.242 · Cited by 33
HSulf‐1 inhibits cell proliferation and invasion in human gastric cancer
Li, J., Mo, M., Zhao, C. F., Yang, J., Li, Q., Wang, D., Zhang, H., Ye, Y., Xu, J., Li, H., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02024.x · Cited by 33
CD44+ gastric cancer cells with stemness properties are chemoradioresistant and highly invasive
Sun, M., Zhou, W., Zhang, Y., Wang, D. Z., & Wu, X. (2013) · Oncology Letters · doi:10.3892/ol.2013.1272 · Cited by 31
Hu, Y., Wan, R., Yu, G., Shen, J., Ni, J., Yin, G., Xing, M., Chen, C., Fan, Y., Xiao, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095145 · Cited by 31
Identification of Aberrantly Expressed miRNAs in Gastric Cancer
Liu, D., Hu, X., Zhou, H., Shi, G., & Wu, J. (2014) · Gastroenterology Research and Practice · doi:10.1155/2014/473817 · Cited by 28
Tong, J., To, K. F., Ng, E. K. W., Lau, J., Lee, T., Lo, K. W., Leung, W. K., Tang, N. L. S., Chan, F. K. L., Sung, J. J. �., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00681-9 · Cited by 28
Yang, Z., Chen, W.-W., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033030 · Cited by 26
TGF-β1 alters microRNA profile in human gastric cancer cells.
Zhou, H., Wang, K., Hu, Z., & Wen, J. (2013) · Chinese Journal of Cancer Research · doi:10.3978/j.issn.1000-9604.2013.01.09 · Cited by 25
Yoo, N. J., Kim, S., & Lee, S. H. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0458-9 · Cited by 25
Tang, S., Mishra, M., Frazier, D. P., Moore, M. L., Inoue, K., Deora, R., Sui, G., & Dubey, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035570 · Cited by 18
Song, J., Wang, Z., & Ewing, R. M. (2013) · Molecular BioSystems · doi:10.1039/c3mb70417c · Cited by 18
Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?
Aituov, B., Duisembekova, A., Bulenova, A., & Alibek, K. (2012) · Infectious Agents and Cancer · doi:10.1186/1750-9378-7-18 · Cited by 18
MicroRNAs are implicated in the initiation and progression of gastric cancer
Jianning, S., Zhigang, B., & Zhongtao, Z. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20122918 · Cited by 17
Varol, N., Konaç, E., Onen, I. H., Gürocak, S., Alp, E., Yılmaz, A., Menevşe, S., & Sözen, S. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2285 · Cited by 14
Cited by
Ajani, J. A., Lee, J., Sano, T., Janjigian, Y. Y., Fan, D., & Song, S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.36 · Cited by 594
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
Ma, B., & Hottiger, M. O. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00378 · Cited by 563
CircRNA: a rising star in gastric cancer
Li, R., Jiang, J., Shi, H., Qian, H., Zhang, X., & Xu, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03345-5 · Cited by 418
Wang, W., Xie, X., Yuan, T., Wang, Y., Zhao, F., Zhou, Z., & Zhang, H. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03809-2 · Cited by 381
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge
Pernot, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11428 · Cited by 314
Metadata
- Authors
- Chiurillo, M. A.
- Venue
- World Journal of Experimental Medicine
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 5
- Issue
- 2
- Pages
- 84
- ISSN
- 2220-315X (ISSN-L)
- OpenAlex
- W808646684
- Cited by
- 317
- References
- 228
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.